Navigation Links
Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
Date:12/16/2010

ROCKVILLE, Md., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"The commencement of the first trial in our small molecule platform represents a major milestone for Neuralstem," said Richard Garr, Neuralstem President & CEO. "In addition to our ongoing programs in cell therapeutics, we are now advancing a new class of orally administered drugs that recruit endogenous neural stem cells.  NSI-189 is the first in this class."

"Today's antidepressants are based on a theory of serotonin deficiency," explained Karl Johe, PhD, Chief Scientific Officer and Chairman of Neuralstem's Board of Directors. "A new theory is emerging that chronic stress can lead to hippocampal atrophy and eventually to depression. NSI-189 appears to help the brain repair itself, generating new neurons and protecting against damage. This neurogenic approach is completely novel in the treatment of CNS diseases."

About NS-189

NS-189 is the first in a class of compounds that Neuralstem plans to develop into orally administered drugs.

In mice, NSI-189 both stimulated neurogenesis of the hippocampus and increased its overall volume as well. Additionally, NSI-189 stimulated neurogenesis of human hippocampus-derived neural stem cells in-vitro. Therefore, NSI-189 may reverse the human hippocampal atrophy seen in major
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
2. Neuralstems ALS Trial on Clinical Hold
3. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
4. Neuralstem Announces Issuance of Core Technology Patent in Europe
5. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
6. Accuray Receives FDA Clearance for the CyberKnife® Systems Lung Optimized Treatment
7. Generex Receives New Patent for Buccal Drug Delivery Platform Technologies
8. Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group
9. Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market
10. Mylan Receives Approval for Generic Version of Adalat® CC Tablets
11. Medical Messengers AstralJet V4 Receives ONC-ATCB 2011/2012 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 24, 2014 ... grow at an average rate of 8.1%. The US ... Hip, knee and spine surgeries are the common orthopedic ... they have a lower penetration. Increased number of product ... composites. Non-metallic orthopedic devices have gained popularity in the ...
(Date:12/24/2014)... , Dec. 23, 2014 Echo ... medical device company focused on skin permeation, continuous ... Scott W. Hollander has been appointed ... Hollander has more than 20 years of experience ... industries, and most recently served as Vice President, ...
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
Breaking Medicine Technology:Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... Aung FootHealth Clinics &,Advanced Wound Care Center today ... foot ulcers to participate in the MATRIX clinical,trial. ... Excellarate(TM) (GAM501),(Ad5PDGF-B/bovine Type I collagen gel) for the ... ulcers. Excellarate is,an investigational product designed to stimulate ...
... participate in controversial debate over effects of ... Simvastatin vs. Ezetimibe/Simvastatin, ... medical professionals, will air on XM Satellite Radio Channel,157 ... a candid medical,discussion on the much talked-about ENHANCE (Effect ...
Cached Medicine Technology:Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial 2ReachMD Broadcasts First-of-its-Kind Physician Peer-Peer Discussion on ENHANCE Trial 2
(Date:12/25/2014)... The microscopy market is estimated ... reach $5,756.0 million by 2019. Optical microscopy is ... electron microscopes product segment is expected to show ... Rising focus on nanotechnology, technological advancements, and increasing ... market. , Get Full Copy of Report @ ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... the business announces a click strand woven bamboo ... 2015. , Click strand woven bamboo flooring replicates ... well-known brand in the bamboo industry. It promises ... bamboo flooring supplier. , “We are happy to ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. TS-1 is an anti-cancer drug which is typically ... and is also used for treating gastric cancer and ... otastat potassium. The drug was first approved in 1999 ...
(Date:12/25/2014)... 26, 2014 “Every three months the trends ... A-line sweetheart evening dress will be one of the hottest ... of Yunx.co.uk says. Today, the company releases 26 A-line sweetheart ... to 80% off. , “We are trying our best ... with our latest designs. Along with affordable prices, we provide ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... 700,000 for each of the 2011 prizes, of which CHF ... CHF 100,000 for their personal use. The prize ... be of considerable significance for medicine. Stefan Jentsch is ... his work on small protein modifiers and their role in ...
... HealthDay Reporter , TUESDAY, Jan. 25 (HealthDay News) ... research finds. Patients with ischemic stroke (involving a blood ... medication and survive if treated at one of these specialty ... published in the Jan. 26 issue of Journal of ...
... Reporter , TUESDAY, Jan. 25 (HealthDay News)-- Prolonged exposure to ... aged 65 and older, a new Danish study finds. ... of road noise, a person,s risk of having a stroke ... that did not translate into a statistically significant risk, but ...
... conducted at Sahlgrenska University Hospital in Gothenburg and at ... of 18 and 65. Half the group was randomly ... half to maintain their usual lifestyle. Both groups ... group increased their physical activity on their own, but ...
... , MONDAY, Jan. 24 (HealthDay News) -- The ... cyclists or pedestrians moving around them isn,t necessarily the result ... a heightened awareness of background movement, a new study from ... person, a part of the brain called the medial temporal ...
... past for children with ACL tears because of the possible damage ... life. With this new technology, surgeons can actually see ... knee, and can safely position the tunnels where they will place ... Medicine Center, and colleagues in the laboratory of Allen R. Tannenbaum, ...
Cached Medicine News:Health News:2011 Louis-Jeantet Prize for Medicine 2Health News:2011 Louis-Jeantet Prize for Medicine 3Health News:2011 Louis-Jeantet Prize for Medicine 4Health News:2011 Louis-Jeantet Prize for Medicine 5Health News:'Stroke Centers' Providing Better Care, Study Finds 2Health News:'Stroke Centers' Providing Better Care, Study Finds 3Health News:Loud Road Noise Linked to Stroke in Older Adults 2Health News:Loud Road Noise Linked to Stroke in Older Adults 3Health News:3-D MRI helps kids with ACL tears -- surgery without harming the growth plate 2
... Indications include painful arthritic deformity of ... the subtalar joint, failed fusion of ... tibial plafond and/or talus where reconstruction ... ankle joint combined with severe arthritic ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
... In 1985, the worlds first ... by Howmedica Osteonics as a means ... wire for trochanteric reattachment procedures. Today, ... papers demonstrating clinical successes, the Dall-Miles™ ...
... The Minimally Invasive Hip Instruments ... THA through a mini-incision using ... set of instruments helps reduce ... invasive THA by optimizing exposure ...
Medicine Products: